简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

Sanmina, Sarepta Therapeutics, Polaris, Celestica And Other Big Stocks Moving Higher On Tuesday

2025-07-29 22:51

U.S. stocks were mixed, with the Dow Jones index falling around 100 points on Tuesday.

Shares of Sanmina Corporation (NASDAQ:SANM) rose sharply during Tuesday's session after the company reported better-than-expected quarterly financial results.

Sanmina reported quarterly earnings of $1.53 per share which beat the analyst consensus estimate of $1.42 per share. The company reported quarterly sales of $2.042 billion which beat the analyst consensus estimate of $1.983 billion.

Sanmina shares jumped 16.7% to $114.78 on Tuesday.

Here are some other big stocks recording gains in today’s session.

  • Sarepta Therapeutics, Inc. (NASDAQ:SRPT) shares jumped 25.3% to $17.37 after the U.S. Food and Drug Administration (FDA) recommended the removal of a voluntary hold for Elevidys.
  • Expro Group Holdings N.V. (NYSE:XPRO) gained 24.2% to $11.18 after the company reported better-than-expected second-quarter financial results and issued FY25 revenue guidance above estimates.
  • Amkor Technology, Inc. (NASDAQ:AMKR) rose 23% to $26.13 after the company reported better-than-expected second-quarter financial results and issued third-quarter sales guidance above estimates.
  • Polaris Inc. (NYSE:PII) gained 21.7% to $60.26 after the company reported better-than-expected quarterly financial results.
  • Rich Sparkle Holdings Limited (NASDAQ:ANPA) rose 21.7% to $31.69.
  • Celestica Inc. (NYSE:CLS) gained 16.7% to $202.41 after the company reported better-than-expected second-quarter financial results and raised its FY25 guidance.
  • Chart Industries, Inc. (NYSE:GTLS) gained 15.9% to $198.99 after the company reported better-than-expected second-quarter adjusted EPS results. Additionally, the company announced that its merger agreement with Flowserve has been terminated, and Baker Hughes will acquire all the outstanding stock of Chart Industries for $210 per share.
  • SoFi Technologies, Inc. (NASDAQ:SOFI) rose 15.5% to $24.30 after the company raised FY25 EPS and sales guidance.
  • Commvault Systems, Inc. (NASDAQ:CVLT) jumped 14.1% to $186.50 after the company reported better-than-expected first-quarter financial results and raised its FY26 sales guidance above estimates.
  • GeneDx Holdings Corp. (NASDAQ:WGS) gained 13.5% to $96.37 after the company raised FY25 sales guidance above estimates.
  • Rambus Inc. (NASDAQ:RMBS) rose 11.3% to $71.48 after the company reported better-than-expected quarterly adjusted EPS and revenue results. Additionally, Susquehanna raised its price target on the stock from $70 to $75.
  • Koninklijke Philips N.V. (NYSE:PHG) gained 10% to $28.24 after the company reported better-than-expected quarterly financial results. Additionally, the company has announced a multi-year agreement with Indonesia’s Ministry of Health to expand image-guided therapy services to hospitals nationwide.
  • Simpson Manufacturing Co., Inc. (NYSE:SSD) rose 9.1% to $181.12 after the company reported second-quarter financial results and beat its EPS and revenue estimates.
  • TTM Technologies, Inc. (NASDAQ:TTMI) gained 8.5% to $49.86.
  • CBRE Group, Inc. (NYSE:CBRE) gained 8.2% to $158.64 after the company reported better-than-expected quarterly financial results and raised its FY25 adjusted EPS guidance above estimates.
  • Synopsys, Inc. (NASDAQ:SNPS) rose 8% to $639.84.
  • Incyte Corporation (NASDAQ:INCY) rose 7.4% to $75.33 following second-quarter results.
  • Modine Manufacturing Company (NYSE:MOD) gained 7% to $112.91 after the company announced a $100 million data center business investment, where it will open a new Dallas facility and expand its Grenada site.
  • Crane Company (NYSE:CR) gained 5.1% to $199.69 after the company reported better-than-expected second-quarter financial results and raised its FY25 adjusted EPS guidance.

Now Read This:

  • Boeing, Procter & Gamble And 3 Stocks To Watch Heading Into Tuesday

Photo via Shutterstock

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。